Cover Image
close this bookHIV in Pregnancy: A Review (UNAIDS, 1999, 67 p.)
View the document(introduction...)
View the documentEXECUTIVE SUMMARY
View the documentINTRODUCTION
close this folderSECTION A : HIV IN PREGNANCY
View the document(introduction...)
View the documentEpidemiology of HIV
close this folderSusceptibility of women to HIV infection
View the document(introduction...)
View the documentBiological factors
View the documentSocio-cultural factors
View the documentEffect of pregnancy on the natural history of HIV infection
View the documentEffect of HIV infection on pregnancy
close this folderMother-to-child transmission
View the document(introduction...)
View the documentFactors affecting mother-to-child transmission of HIV-1
View the documentInterventions to prevent mother-to-child transmission of HIV
close this folderAppropriate interventions to reduce mother-to-child transmission
View the document(introduction...)
View the documentAntiretroviral therapy
View the documentImmune therapy
View the documentNutritional interventions
View the documentMode of delivery
View the documentVaginal cleansing
View the documentModification of infant feeding practice
close this folderVoluntary HIV counselling and testing in pregnancy
View the document(introduction...)
View the documentTesting of antenatal women
View the documentCounselling before and after HIV testing in pregnancy
View the documentCounselling about pregnancy-related issues
close this folderSECTION B : MANAGEMENT OF HIV-POSITIVE PREGNANT WOMEN
View the document(introduction...)
close this folderAntenatal care
View the document(introduction...)
View the documentObstetrical management
View the documentExamination and investigations
View the documentMedical treatment during pregnancy
View the documentAntiretroviral therapy
View the documentCare during labour and delivery
View the documentPostpartum care
View the documentCare of neonates
close this folderSECTION C : INFECTION CONTROL MEASURES
View the document(introduction...)
View the documentUniversal precautions
close this folderRisks of needlestick injuries
View the document(introduction...)
View the documentManagement of needlestick injuries and other accidental blood exposure
View the documentREFERENCES

(introduction...)

The ideal intervention for the reduction of mother-to-child transmission would be one that is widely applicable in resource poor settings252. Vaginal disinfection and vitamin A administration would not require identification of HIV positive women, but would be applicable to all pregnant women. The minimum requirements for the implementation of other interventions in health services include253:

· access to and use of appropriate antenatal, intrapartum and postpartum care with adequately trained health workers

· adequate pre and post test counselling services

· ability to afford the cost of reliable HIV testing

· appropriate laboratory facilities to monitor blood parameters during long regimen

· delivery units with access to disinfectants, gloves and clean needles

· acceptance and uptake of the intervention by HIV-infected women

· a regimen that is logistically possible to implement in terms of dosing times and routes, drug storage and distribution

· a regimen which is affordable for the health service.

The widespread implementation of strategies to prevent mother-to-child transmission of HIV presents a number of challenges to the existing antenatal and obstetric services. The need for such strategies is greatest in the most resource constrained settings. The provision of interventions to prevent mother-to-child transmission of HIV should not further overburden existing services. In many areas, antenatal care services are not sufficiently available, accessible or utilized and they may not be of adequate quality to take on these interventions. These services will need to be strengthened in the years ahead in order to deliver mother-to-child transmission prevention strategies effectively.

In addition if interventions are introduced into clinical practice to decrease the risk of mother-to-child transmission their effectiveness outside of the context of a randomized controlled trial should be monitored. Careful follow-up of the mothers and infants of such programmes will be essential to determine the generalisability of clinical trial results to the practical setting.

The management of HIV infection and AIDS is changing rapidly. New drugs become available and are rapidly adopted into clinical practice with little rigorous evaluation of their effectiveness. In pregnancy the situation is little different. Within one month in 1999, four substantial randomized trials of interventions aimed at decreasing the risk of mother-to-child transmission of HIV infection were published. Many more trials are on-going and can be expected to report in the next two years. The following section, therefore, represents the evidence that was available at the end of May 1999. As new randomized trials are published they will be incorporated into an ongoing systematic review and meta-analysis of interventions aimed at decreasing the risk of mother-to-child transmission of HIV infection published in the Cochrane Library254.